Unknown

Dataset Information

The cellular response to drug perturbation is limited: comparison of large-scale chemogenomic fitness signatures.


ABSTRACT:

Background

Chemogenomic profiling is a powerful approach for understanding the genome-wide cellular response to small molecules. First developed in Saccharomyces cerevisiae, chemogenomic screens provide direct, unbiased identification of drug target candidates as well as genes required for drug resistance. While many laboratories have performed chemogenomic fitness assays, few have been assessed for reproducibility and accuracy. Here we analyze the two largest independent yeast chemogenomic datasets comprising over 35 million gene-drug interactions and more than 6000 unique chemogenomic profiles; the first from our own academic laboratory (HIPLAB) and the second from the Novartis Institute of Biomedical Research (NIBR).

Results

Despite substantial differences in experimental

SUBMITTER: Barazandeh M 

PROVIDER: S-EPMC8915488 | biostudies-literature | 2022 Mar

REPOSITORIES: biostudies-literature